Back to search
FDAFDA · Food and drugs·Recall number D-0001-2021

Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06

Published October 7, 2020 · Recall initiated: August 24, 2020

Summary

FDA records drug Class II recall D-0001-2021, published October 7, 2020 and initiated August 24, 2020. Recalling firm: Strides Inc.; Status: Terminated; Reported quantity: 11,280 bottles; Lot: 7240675A; Exp. 12/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if POTASSIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
POTASSIUM CHLORIDE
Manufacturer
Strides Inc.
Distributor
nationwide
UPC
0364380860068
Lot
7240675A; Exp. 12/31/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06 recalled?

Yes. FDA published recall D-0001-2021 on October 7, 2020. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: POTASSIUM CHLORIDE. UPC: 0364380860068.